We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pharmaceutical Company Seeks High Court Review In Trademark Dispute

(November 3, 2016, 5:14 PM EDT) -- WASHINGTON, D.C. — A pharmaceutical company in an Oct. 20 petition for writ of certiorari asks the U.S. Supreme Court to answer whether Sections 14(3) and 43(a) of the Lanham Act...
To view the full article, register now.